PHILADELPHIA - U.S. Attorney William M. McSwain announced that an indictment was unsealed today charging a Philadelphia pharmacy employee with conspiring to distribute controlled substances, including opioid painkillers.
Anmol Singh Kamra, 25, of Newtown Square, is charged with one count of conspiring with a doctor and another individual to distribute tens of thousands of tablets of oxycodone, a Schedule II controlled substance, in violation of federal drug law. Schedule II controlled substances have a high potential for abuse and may lead to severe psychological and physical dependence.
This case is part of a nationwide Department of Justice initiative targeting individuals who contribute to the opioid epidemic, with a particular focus on medical professionals involved in the unlawful distribution of opioids and other prescription narcotics. According to the Centers for Disease Control and Prevention, approximately 91 Americans die every day of an opioid related overdose.
“We have to do everything in our power to make sure those who contribute to the destructive and deadly opioid crisis are held accountable," said U.S. Attorney McSwain. “Too many Americans are dying. That’s why prosecuting those who traffic in opioids is a priority for the Department of Justice and for our Office."
The indictment alleges the following:
Kamra worked at Campus Pharmacy at 4027 Market Street in Philadelphia, Pennsylvania. From about December 2012 through March 2016, Kamra filled hundreds of prescriptions for oxycodone knowing that the prescriptions were fraudulent.
Frank D. Brown, charged elsewhere, frequented a doctor’s office to obtain multiple sham prescriptions for controlled substances, including oxycodone, under both his own name and the names of others. Brown paid cash for these sham prescriptions. In December 2012, after purchasing the sham prescriptions, Brown began going to Campus Pharmacy, where Kamra would fill these sham prescriptions in exchange for cash.
Kamra, Brown, and the doctor used over 30 different names when filling and dispensing prescriptions at Campus Pharmacy. After obtaining the oxycodone tablets from Kamra, Brown sold the pills on the street to drug users in exchange for cash. Over time, Kamra provided oxycodone pills even when Brown failed to provide any prescription for those pills.
If convicted, Kamra faces a maximum possible sentence of 20 years’ imprisonment, a minimum of 3 years up to a lifetime of supervised release, a $1,000,000 fine, and a $100 special assessment.
The unsealing of today’s indictment was coordinated with the Criminal Division, Fraud Section’s Health Care Fraud Unit as part of its National Health Care Fraud Takedown. The case was investigated by the Federal Bureau of Investigation and the Drug Enforcement Administration Diversion Unit. It is being prosecuted by Assistant United States Attorney Jessica Natali.
Source: U.S. Department of Justice, Federal Bureau of Investigation (FBI)
